1-naphthylamine has been researched along with Granulocytic Leukemia, Chronic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cui, L; Du, X; Jin, B; Jin, Y; Li, J; Li, P; Pan, J; Ren, R; Wang, Y; Xu, F; Zhou, J | 1 |
1 other study(ies) available for 1-naphthylamine and Granulocytic Leukemia, Chronic
Article | Year |
---|---|
Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia.
Topics: 1-Naphthylamine; Aminoquinolines; Animals; Antineoplastic Agents; Carbazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme Induction; Female; Fusion Proteins, bcr-abl; Gene Expression; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HEK293 Cells; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Neoplastic Stem Cells; Protein-Arginine N-Methyltransferases; Pyrimidines; RNA, Small Interfering; STAT5 Transcription Factor; Xenograft Model Antitumor Assays | 2016 |